Connor, Clark & Lunn Investment Management Ltd. Insulet Corp Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $18.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023
BUY
$272.48 - $330.23 $40,599 - $49,204
149 Added 2.79%
5,499 $1.59 Million
Q1 2023

May 09, 2023
SELL
$276.36 - $326.03 $402,932 - $475,351
-1,458 Reduced 21.42%
5,350 $1.71 Million
Q4 2022

Feb 10, 2023
BUY
$212.22 - $313.46 $1.44 Million - $2.13 Million
6,808 New
6,808 $2 Million
Q4 2019

Feb 12, 2020
BUY
$144.81 - $186.0 $354,784 - $455,700
2,450 New
2,450 $419,000

Others Institutions Holding PODD

# of Institutions
687
Shares Held
62.6M
Call Options Held
640K
Put Options Held
881K
View Full List

About INSULET CORP

PODD Quotes by TradingView
  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.4B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email